Plant protein shows promise against oral cancer in early study
NCT ID NCT04188665
First seen Apr 07, 2026 · Last updated May 25, 2026 · Updated 7 times
Summary
This early-phase study looked at whether a plant protein called MASL can target a receptor (podoplanin) found on oral cancer cells. Researchers tested cells from 18 people with oral cancer or precancerous lesions to see if MASL could slow growth. The goal was to understand how the receptor works and if MASL might be a future treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New Jersey Medical School
Newark, New Jersey, 07103, United States
-
Rowan University
Stratford, New Jersey, 08084, United States
-
Rutgers School for Dental Medicine
Newark, New Jersey, 07103, United States
-
University Hospital
Newark, New Jersey, 07103, United States
Conditions
Explore the condition pages connected to this study.